MLK3 Signaling in Cancer Invasion
AbstractMixed-lineage kinase 3 (MLK3) was first cloned in 1994; however, only in the past decade has MLK3 become recognized as a player in oncogenic signaling. MLK3 is a mitogen-activated protein kinase kinase kinase (MAP3K) that mediates signals from several cell surface receptors including receptor tyrosine kinases (RTKs), chemokine receptors, and cytokine receptors. Once activated, MLK3 transduces signals to multiple downstream pathways, primarily to c-Jun terminal kinase (JNK) MAPK, as well as to extracellular-signal-regulated kinase (ERK) MAPK, P38 MAPK, and NF-κB, resulting in both transcriptional and post-translational regulation of multiple effector proteins. In several types of cancer, MLK3 signaling is implicated in promoting cell proliferation, as well as driving cell migration, invasion and metastasis. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Rattanasinchai, C.; Gallo, K.A. MLK3 Signaling in Cancer Invasion. Cancers 2016, 8, 51.
Rattanasinchai C, Gallo KA. MLK3 Signaling in Cancer Invasion. Cancers. 2016; 8(5):51.Chicago/Turabian Style
Rattanasinchai, Chotirat; Gallo, Kathleen A. 2016. "MLK3 Signaling in Cancer Invasion." Cancers 8, no. 5: 51.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.